Aviva’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Sell
1,722
-385
-18% -$65.4K ﹤0.01% 828
2025
Q4
$323K Buy
+2,107
New +$322K ﹤0.01% 850
2023
Q4
Sell
-4,533
Closed -$562K 1031
2023
Q3
$562K Sell
4,533
-6,302
-58% -$838K ﹤0.01% 858
2023
Q2
$1.46M Sell
10,835
-486
-4% -$62.5K 0.01% 726
2023
Q1
$1.43M Buy
11,321
+3,718
+49% +$481K 0.01% 788
2022
Q4
$928K Sell
7,603
-4,409
-37% -$582K ﹤0.01% 903
2022
Q3
$1.46M Sell
12,012
-4,484
-27% -$584K 0.01% 832
2022
Q2
$2.14M Buy
16,496
+288
+2% +$36K 0.01% 765
2022
Q1
$2.22M Buy
16,208
+552
+4% +$79.1K 0.01% 803
2021
Q4
$2.64M Buy
15,656
+3,452
+28% +$554K 0.01% 749
2021
Q3
$1.77M Buy
+12,204
New +$1.65M 0.01% 775
2021
Q2
Sell
-9,526
Closed -$1.2M 989
2021
Q1
$1.2M Sell
9,526
-3,653
-28% -$444K 0.01% 857
2020
Q4
$1.52M Sell
13,179
-10,686
-45% -$1.13M 0.01% 758
2020
Q3
$2.33M Sell
23,865
-346
-1% -$33.9K 0.01% 667
2020
Q2
$2.3M Sell
24,211
-13,487
-36% -$1.26M 0.01% 695
2020
Q1
$3.72M Buy
37,698
+18,758
+99% +$1.92M 0.03% 527
2019
Q4
$1.93M Buy
+18,940
New +$1.91M 0.01% 757

Other funds holding BCPC

Aviva's BCPC Position: Q1 2026 in Review

Aviva reduced its Balchem Corp (BCPC) stake by 18% in Q1 2026, selling an estimated $65.4K and leaving 1,722 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Aviva first reported a position in BCPC in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.72M in Q1 2020. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Aviva held 1,722 shares of Balchem Corp worth $292K as of Q1 2026.
  • Aviva sold 385 Balchem Corp shares in Q1 2026, an estimated $65.4K.
  • Balchem Corp made up ﹤0.01% of Aviva's portfolio in Q1 2026, its #828 holding.
  • Aviva first reported a position in Balchem Corp in Q4 2019 and has held it in 17 quarters since.
  • Aviva's Balchem Corp position peaked at $3.72M in Q1 2020.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.